Evaluation of Drug Utilization Patterns for Extended Release/Long Acting Opioids and Comparator Products

NCT02925806 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5575834

Last updated 2016-10-06

No results posted yet for this study

Summary

A drug utilization study will be performed to describe trends in the number of prescriptions and patients for class REMS ER/LA opioids and comparator products.

Conditions

  • Opioid Related Disorders
  • Opiate Addiction
  • Narcotic Abuse
  • Drug Abuse

Interventions

OTHER

Non-interventional study - retrospective database review

Sponsors & Collaborators

  • ER/LA Opioid REMS Program Companies (RPC)

    lead INDUSTRY

Eligibility

Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Primary Completion
2019-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02925806 on ClinicalTrials.gov